How Heart Specialists Benefit From Medicare’s TAVR Restrictions

For 14 years, patient access to TAVR has been restricted for Medicare beneficiaries under a Coverage with Evidence ...
Health Affairs

Medicare “Coverage With Evidence Development” Leaps Into The Spotlight With CMS Draft National Coverage Decision On Alzheimer’s Drugs

The Centers for Medicare & Medicaid Services (CMS) issued a ground-breaking draft national coverage decision (NCD) on January 11, 2022, for Food & Drug Administration (FDA) approved monoclonal ...
Becker's Hospital Review

CMS creates Office of Health Technology and Products

The Centers for Medicare & Medicaid Services has established a new Office of Health Technology and Products to oversee healthcare technology modernization, digital products and platform transformation ...
JD Supra

CMS “Splits the Baby” on Aduhelm—Medicare Coverage But Only with Evidence Development for Now

On January 11, 2022, the Centers for Medicare and Medicaid Services (“CMS”) published an anticipated proposed National Coverage Determination (“NCD”) decision memorandum that begins the process of ...
JD Supra

CMS Proposes Guidance on Use of Real World Data for Coverage with Evidence Development

Real world data (RWD), which is data from actual patient treatments, provides valuable information on safety and effectiveness of innovative new health technologies, often at significantly lower cost ...
Becker's Hospital Review

CMS to Offer Final ACO Accelerated Development Learning Session in D.C.

CMS’ Innovation Center is offering the third and final session of its ACO Accelerated Development Learning Sessions. ACO Accelerated Development Learning Sessions are designed to provide executive ...